EUDA
EUDA Health Holdings LimitedNASDAQREAL ESTATEREAL ESTATE SERVICES
Key Statistics
Market Cap
$11.15M
P/E Ratio
14.75
EPS
$0.40
Beta
0.16
52W High
$86.00
52W Low
$5.26
50-Day MA
$12.36
200-Day MA
$39.20
Dividend Yield
—
Profit Margin
5.17%
Forward P/E
3.65
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies addressing rare diseases and unmet medical needs. Leveraging cutting-edge technologies and a robust clinical pipeline, the company focuses on pivotal areas such as supportive care and immune modulation. With a strong commitment to research and development, EUDA is poised to advance healthcare innovation and enhance patient outcomes, while striving to broaden access to essential medical therapies through its promising clinical initiatives.
Fundamentals
| Revenue (TTM) | $5.16M |
| Gross Profit (TTM) | $1.16M |
| EBITDA | $-1.99M |
| Operating Margin | -37.00% |
| Return on Equity | 0.00% |
| Return on Assets | -63.90% |
| Revenue/Share (TTM) | $2.80 |
| Book Value | $-2.00 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 2.16 |
| EV/Revenue | 3.257 |
| EV/EBITDA | -25.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 60.20% |
| Shares Outstanding | $1.89M |
| Float | $1.17M |
| % Insiders | 37.28% |
| % Institutions | 0.09% |
Historical Volatility
HV 10-Day
116.95%
HV 20-Day
166.79%
HV 30-Day
183.84%
HV 60-Day
160.63%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/21/2026